The relationship between antipsychotic medication adherence and patient outcomes among individuals diagnosed with bipolar disorder: A retrospective study

Annals of General Psychiatry

Volumn 8, Issue , 2009, Pages

  Lage, Maureen J ^a   Hassan, Mariam K ^b  

^a HealthMetrics Outcomes Research LLC   (United States)

^b ASTRAZENECA   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DROPERIDOL; FLUOXETINE; FLUPHENAZINE; HALOPERIDOL; LOXAPINE; MESORIDAZINE; MOLINDONE; NEUROLEPTIC AGENT; OLANZAPINE; PERPHENAZINE; PIMOZIDE; PIPERACETAZINE; PROMAZINE; QUETIAPINE; RISPERIDONE; THIORIDAZINE; TIOTIXENE; TRIFLUOPERAZINE; TRIFLUPROMAZINE; ZIPRASIDONE;

ADULT; ARTICLE; BIPOLAR DISORDER; EMERGENCY WARD; FEMALE; FOLLOW UP; HEALTH STATUS; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; PATIENT COMPLIANCE; PRESCRIPTION; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK REDUCTION;

EID: 62149104818     PISSN: None     EISSN: 1744859X     Source Type: Journal    
DOI: 10.1186/1744-859X-8-7     Document Type: Article

References (36)

1. Murray CJ Lopez AD eds The global burden of disease: A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. (Global Burden of disease and Injury Series, Vol. 1) Cambridge, MA, USA: Harvard University Press 1996
2. Kessler RC Chiu WT Demler O Merikangas KR Walters EE Prevalence, severity, and comorbidity of twelve-month DSM-IV disorders in the National Comorbidity Survey Replication (NCS-R) Arch Gen Psychiatry 2005, 62:617-627 10.1001/archpsyc.62.6.617 15939839
3. Blader JC Carlson GA Increased rates of bipolar disorder diagnoses among U.S. child, adolescent, and adult inpatients, 1996-2004 Biol Psychiatry 2007, 62:107-114 2001259 17306773 10.1016/j.biopsych.2006.11.006
4. Merikangas KR Akiskal HS Angst J Greenberg PE Hirschfeld RM Petukhova M Kessler RC Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication Arch Gen Psychiatry 2007, 64:543-552 1931566 17485606 10.1001/archpsyc.64.5.543
5. Wyatt RJ Henter I An economic evaluation of manic depressive illness - 1991 Soc Psychiatry Psychiatr Epidemiol 1995, 30:213-219 7482006
6. Begley CE Annegers JF Swann AC Lewis C Coan S Schnapp WB Bryant-Comstock L The lifetime cost of bipolar disorder in the US: An estimate for new cases in 1998 Pharmacoeconomics 2001, 19:483-495 10.2165/ 00019053-200119050-00004 11465308
7. Peele PB Xu Y Kupfer DJ Insurance expenditures on bipolar disorder: clinical and parity implications Am J Psychiatry 2003, 160:1286-1290 10.1176/appi.ajp.160.7.1286 12832243
8. Goetzel RZ Hawkins K Ozminkowski RJ Wang S The health and productivity cost burden of the "top 10" physical and mental health conditions affecting six large US employers in 1999 Occup Environ Med 2003, 45:5-14 10.1097/00043764-200301000-00007
9. Stensland MD Jacobson JG Nyhuis A Service utilization and associated direct costs for bipolar disorder in 2004: An analysis in managed care J Affect Disord 2007, 101:187-193 10.1016/j.jad.2006.11.019 17254637
10. Wyatt RJ Henter I Leary MC Taylor E An economic evaluation of schizophrenia, 1991 Soc Psychiatry Psychiatr Epidemiol 1995, 30:196-205 7482004
11. Sachs GS Printz DJ Kahn DA Carpenter D Docherty JP The expert consensus guideline series: Medication treatment of bipolar disorder 2000 Postgrad Med 2000 Spec No 1-104 10895797
12. Sachs GS Thase ME Bipolar disorder therapeutics: Maintenance treatment Biol Psychiatry 2000, 48:573-81 10.1016/S0006-3223(00)00991-4 11018228
13. Colom F Vieta E Martínez-Arán A Reinares M Benabarre A Gastó C Clinical factors associated with treatment noncompliance in euthymic bipolar patients J Clin Psychiatry 2000, 61:549-555 10982196
14. Lehmann SW Rabins PV Factors related to hospitalization in elderly manic patients with early and late-onset bipolar disorder Int J Geriatr Psychiatry 2006, 21:1060-1064 10.1002/gps.1607 16955445
15. Svarstad BL Shireman TI Sweeney JK Using drug claims data to assess the relationship of medication adherence with hospitalization and costs Psychiatr Serv 2001, 52:805-811 10.1176/appi.ps.52.6.805 11376229
16. Scott J Pope M Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization Am J Psychiatry 2002, 159:1927-1929 10.1176/appi.ajp.159.11.1927 12411230
17. Keck PE Jr McElroy SL Strakowski SM Stanton SP Kizer DL Balistreri TM Bennett JA Tugrul KC West SA Factors associated with pharmacologic noncompliance in patients with mania J Clin Psychiatry 1996, 57(7):292-297 8666570
18. Jamison KR Gerner RH Goodwin FK Patient and physician attitudes toward lithium: Relationship to compliance Arch Gen Psychiatry 1979, 36:866-869 454105
19. Sajatovic M Valenstein M Blow FC Ganoczy D Ignacio RV Treatment adherence with antipsychotic medications in bipolar disorder Bipolar Disord 2006, 8:232-241 10.1111/j.1399-5618.2006.00314.x 16696824
20. International Society for Pharmacoeconomics and Outcomes Research ISPOR Medication Compliance and Persistence Special Interest Group (MCP): Standardizing Definition of Terms http://www.ispor.org/sigs/ MCP_accomplishments.asp#definition
21. Cantrell CR Eaddy MT Shah MB Regan TS Sokol MC Methods for evaluating patient adherence to antidepressant therapy: A real-world comparison of adherence and economic outcomes Med Care 2006, 44:300-303 10.1097/ 01.mlr.0000204287.82701.9b 16565629
22. Mattke S Jain AK Sloss EM Hirscher R Bergamo G O'Leary JF Effect of disease management on prescription drug treatment: What is the right quality measure? Dis Manag 2007, 10:91-100 10.1089/dis.2006.635 17444794
23. Quan H Sundararajan V Halfon P Fong A Burnand B Luthi JC Saunders LD Beck CA Feasby TE Ghali WA Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data Med Care 2005, 43:1130-1139 10.1097/01.mlr.0000182534.19832.83 16224307
24. Charlson ME Pompei P Ales KL MacKenzie CR A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation J Chronic Dis 1987, 40:373-383 10.1016/0021-9681(87)90171-8 3558716
25. Keck PE Jr McElroy SL Strakowski SM Bourne ML West SA Compliance with maintenance treatment in bipolar disorder Psychopharmacol Bull 1997, 33:87-91 9133756
26. Olfson M Marcus SC Wilk J West JC Awareness of illness and nonadherence to antipsychotic medications among persons with schizophrenia Psychiatr Serv 2006, 57:205-211 10.1176/appi.ps.57.2.205 16452697
27. Colom F Vieta E Treatment adherence in bipolar patients Clin Appr Bipolar Dis 2002, 1:49-56
28. Lew KH Chang EY Rajagopalan K Knoth RL The effect of medication adherence on health care utilization in bipolar disorder Manag Care Interface 2006, 19:41-46 17017312
29. Scranton RE Lawler E Botteman M Chittamooru S Gagnon D Lew R Harnett J Gaziano JM Effect of treating erectile dysfunction on management of systolic hypertension Am J Cardiol 2007, 100:459-463 10.1016/ j.amjcard.2007.03.045 17659929
30. Siegel D Lopez J Meier J Antihypertensive medication adherence in the Department of Veterans Affairs Am J Med 2007, 120:26-32 10.1016/ j.amjmed.2006.06.028 17208076
31. Lau DT Nau DP Oral antihyperglycemic medication nonadherence and subsequent hospitalization among individuals with type 2 diabetes Diabetes Care 2004, 27:2149-2153 10.2337/diacare.27.9.2149 15333476
32. Cramer J Rosenheck R Kirk G Krol W Krystal J VA Naltrexone Study Group 425 Medication compliance feedback and monitoring in a clinical trial: predictors and outcomes Value Health 2003, 6:566-573 10.1046/ j.1524-4733.2003.65269.x 14627063
33. Cramer JA Roy A Burrell A Fairchild CJ Fuldeore MJ Ollendorf DA Wong PK Medication compliance and persistence: Terminology and definitions Value Health 2008, 11:44-47 18237359
34. Waeber B Leonetti G Kolloch R McInnes GT Compliance with aspirin or placebo in the Hypertension Optimal Treatment (HOT) study J Hypertens 1999, 17:1041-1045 10.1097/00004872-199917070-00022 10419079
35. Claxton AJ Cramer J Pierce C A systematic review of the associations between dose regimens and medication compliance Clin Ther 2001, 23:1296-1310 10.1016/S0149-2918(01)80109-0 11558866
36. World Health Organization Adherence to long-term therapies: Evidence for action http://www.who.int/chp/knowledge/publications/adherence_report/en/ index.html